# Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines

> **NCT00735020** · PHASE1 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 72 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Adjuvanted Influenza Vaccine
- **BIOLOGICAL:** Influenza Vaccine

## Key facts

- **NCT ID:** NCT00735020
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2014-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735020, "Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00735020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*